Cargando…
Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122450/ https://www.ncbi.nlm.nih.gov/pubmed/35014205 http://dx.doi.org/10.1002/vms3.732 |
_version_ | 1784711347469025280 |
---|---|
author | Nahvi, Atefeh Molaei, Mohammad Mahdi Samimi, Amir Saeed Azari, Omid Mashayekhi, Hossein Ebrahimzadeh, Fatemeh |
author_facet | Nahvi, Atefeh Molaei, Mohammad Mahdi Samimi, Amir Saeed Azari, Omid Mashayekhi, Hossein Ebrahimzadeh, Fatemeh |
author_sort | Nahvi, Atefeh |
collection | PubMed |
description | BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg(−1)); detomidine (50 μg kg(−1)); medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. RESULTS: Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α(2)‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α(2)‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α(2)‐adrenergic agonists’ administration. Ruminal motility was decreased in α(2)‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α(2)‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. CONCLUSIONS: The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg(−1)), detomidine (50 μg kg(−1)), medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats. |
format | Online Article Text |
id | pubmed-9122450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91224502022-05-21 Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats Nahvi, Atefeh Molaei, Mohammad Mahdi Samimi, Amir Saeed Azari, Omid Mashayekhi, Hossein Ebrahimzadeh, Fatemeh Vet Med Sci RUMINANTS BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg(−1)); detomidine (50 μg kg(−1)); medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. RESULTS: Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α(2)‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α(2)‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α(2)‐adrenergic agonists’ administration. Ruminal motility was decreased in α(2)‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α(2)‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. CONCLUSIONS: The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg(−1)), detomidine (50 μg kg(−1)), medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats. John Wiley and Sons Inc. 2022-01-11 /pmc/articles/PMC9122450/ /pubmed/35014205 http://dx.doi.org/10.1002/vms3.732 Text en © 2022 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RUMINANTS Nahvi, Atefeh Molaei, Mohammad Mahdi Samimi, Amir Saeed Azari, Omid Mashayekhi, Hossein Ebrahimzadeh, Fatemeh Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title | Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title_full | Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title_fullStr | Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title_full_unstemmed | Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title_short | Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
title_sort | evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats |
topic | RUMINANTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122450/ https://www.ncbi.nlm.nih.gov/pubmed/35014205 http://dx.doi.org/10.1002/vms3.732 |
work_keys_str_mv | AT nahviatefeh evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats AT molaeimohammadmahdi evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats AT samimiamirsaeed evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats AT azariomid evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats AT mashayekhihossein evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats AT ebrahimzadehfatemeh evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats |